Oric Pharmaceuticals Inc at Citi Virtual Oncology Leadership Summit Transcript
Great. Welcome, everyone. Thanks for sticking with us through the afternoon hours of our first day of the Virtual Oncology Leadership Summit. As you know, I'm Yigal Nochomovitz, that's one of the biotech analyst here at Citigroup. (Conference Instructions)
So with that, it's my great pleasure to have with me senior leadership on ORIC, Jacob Chacko, the CEO; Dominic Piscitelli, CFO; Pratik Multani, the CMO. So thank you all so much for taking the time. It's a story than a lot of the people listening are familiar with.
Questions & Answers
But nonetheless, Jacob, I think helpful to set the stage for us. Give us a quick sense of the pipeline. What are the key priorities for the company over the course of 2024?
Sure. Thank you for having, Yigal. I think most folks are well familiar with the pipeline, so I keep my introductory comments quite quick. We are a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |